IMMUTEP Ltd Logo

IMMUTEP Ltd

Biotechnology company developing LAG-3 immunotherapies for cancer and autoimmune diseases.

IMMP | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE, SYDNEY,

Description

Immutep Ltd. is a late clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. As a pioneer in its field, the company focuses on therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's diversified portfolio is designed to harness LAG-3 to either stimulate the immune response to fight cancer or modulate it to combat autoimmune diseases. Its lead product candidate is eftilagimod alfa, a soluble LAG-3 fusion protein under investigation in multiple oncology trials. The company maintains a pipeline of several clinical-stage assets targeting areas of high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-22 21:11
6-K
English ZIP 28.6 KB
2025-12-16 20:47
6-K
English ZIP 42.7 KB
2025-12-09 12:00
FORM 6-K
English ZIP 61.1 KB
2025-12-03 00:15
FORM 6-K
English ZIP 24.3 KB
2025-11-14 02:39
FORM 6-K
English ZIP 59.2 KB
2025-11-04 00:48
6-K
English ZIP 33.5 KB
2025-10-30 11:00
6-K
English ZIP 47.3 KB
2025-10-24 13:17
20-F
English ZIP 3.3 MB
2025-10-21 22:59
6-K
English ZIP 32.0 KB
2025-10-21 02:00
6-K
English ZIP 25.1 KB
2025-10-14 12:02
6-K
English ZIP 22.5 KB
2025-10-09 23:27
6-K
English ZIP 121.0 KB
2025-09-23 03:11
6-K
English ZIP 119.4 KB
2025-09-03 00:09
6-K
English ZIP 341.1 KB
2025-08-07 01:14
6-K
English ZIP 42.5 KB

Automate Your Workflow. Get a real-time feed of all IMMUTEP Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUTEP Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUTEP Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.